Find recruiting clinical trials for chronic kidney disease (CKD) in the UK — including stage 3-5, dialysis, and post-transplant studies. See treatment pathways and where trials fit in.
Free to use — Live data from ClinicalTrials.gov — Updated hourly
Answer a few questions about your condition and we'll match you to the most relevant clinical trials.
See where clinical trials fit into your treatment journey
eGFR 30-59, moderate decline
Standard: ACEi/ARB, SGLT2 inhibitor (Dapagliflozin), blood pressure control
eGFR 15-29
Standard: Optimise renoprotective therapy, prepare for renal replacement
End-stage kidney disease
Standard: Haemodialysis, peritoneal dialysis, or kidney transplant
Kidney damage caused by diabetes — the most common cause of CKD. SGLT2 inhibitors have revolutionised treatment, slowing progression significantly.
The most common primary glomerulonephritis. New targeted therapies including Nefecon and targeted-release budesonide are showing promise.
After kidney transplantation. Trials focus on improving graft survival, reducing immunosuppression side effects, and preventing rejection.
Loading trials from ClinicalTrials.gov...
SGLT2 inhibitors (Dapagliflozin, Empagliflozin) were originally diabetes drugs but are now proven to slow kidney disease progression regardless of diabetes status. They are a major breakthrough in CKD treatment.
Yes. Many trials specifically target non-diabetic CKD including IgA nephropathy, polycystic kidney disease, FSGS, and other glomerular diseases. SGLT2 inhibitors are now being studied in these populations too.
Some trials specifically recruit dialysis patients, studying new dialysis techniques, anaemia management, phosphate binders, or transitions to transplant. Check eligibility criteria for dialysis-specific trials.
Use our search above to find trials that match your condition and location. Review the eligibility criteria carefully.
Talk to your GP or specialist about any trials you are interested in. They can help determine if a trial is appropriate for you.
Reach out to the trial team directly using the contact information on the ClinicalTrials.gov listing. They will guide you through screening.
If you meet the criteria and decide to participate, you will go through informed consent and begin the trial process.